Send mail to Author

Phase I/II study of the deacetylase inhibitor panobinostat after allogeneic stem cell transplantation in patients with high-risk MDS or AML (PANOBEST trial) (Article)

Please indicate your contact information and select, which author you want to contact.



 
  _____    _    _     ______    ______    ______     ___    
 /  ___|| | || | ||  /_____//  /_   _//  /_   _//   / _ \\  
| // __   | || | ||  `____ `    -| ||-   `-| |,-   / //\ \\ 
| \\_\ || | \\_/ ||  /___//     _| ||_     | ||   |  ___  ||
 \____//   \____//   `__ `     /_____//    |_||   |_||  |_||
  `---`     `---`    /_//      `-----`     `-`'   `-`   `-` 
                     `-`                                    
 


Back to frontdoor view